PE20010330A1 - Androgenos oralmente activos - Google Patents
Androgenos oralmente activosInfo
- Publication number
- PE20010330A1 PE20010330A1 PE2000000702A PE0007022000A PE20010330A1 PE 20010330 A1 PE20010330 A1 PE 20010330A1 PE 2000000702 A PE2000000702 A PE 2000000702A PE 0007022000 A PE0007022000 A PE 0007022000A PE 20010330 A1 PE20010330 A1 PE 20010330A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- orally active
- hydroxystra
- dien
- ona
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0074—Esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
SE REFIERE A 14 NANDROLONA 7O-SUSTITUIDO DERIVADOS DE 19-NORTESTOSTERONA DE FORMULA I, DONDE: R1 ES O, (H,H), (H,OR), NOR; R ES H, ALQUILO C1-C6, ACILO C1-C6; R2 ES ALQUILO C2-C4, ALQUENILO C2-C4, ALQUINILO C2-C4 OPCIONALMENTE SUSTITUIDO CON HALOGENO; R2 ES CICLOPROPILO, CICLOPROPENILO OPCIONALMENTE SUSTITUIDO CON ALQUILO C1-C2, HALOGENO; R3 ES H, ALQUILO C1-C2; R4 ES ALQUILO C1-C2; R5 ES H, ACILO C1-C15. UN COMPUESTO PREFERIDO ES (7O,17ß)-7-ETIL-17-HIDROXIESTRA-4,14-DIEN-3-ONA, (7O,17ß)-7-ETENIL-17-HIDROXIESTRA-4,14-DIEN-3-ONA. LOS COMPUESTOS I SON ANDROGENOS UTILES PARA EL TRATAMIENTO DE LA INSUFICIENCIA ANDROGENICA Y COMO ANTICONCEPTIVO MASCULINO
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99202348 | 1999-07-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20010330A1 true PE20010330A1 (es) | 2001-03-22 |
Family
ID=8240463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2000000702A PE20010330A1 (es) | 1999-07-16 | 2000-07-14 | Androgenos oralmente activos |
Country Status (28)
Country | Link |
---|---|
US (3) | US6313108B1 (es) |
EP (1) | EP1203011B1 (es) |
JP (1) | JP2003505394A (es) |
KR (1) | KR20020092890A (es) |
CN (1) | CN1360589A (es) |
AR (1) | AR024746A1 (es) |
AT (1) | ATE257159T1 (es) |
AU (1) | AU770412B2 (es) |
BR (1) | BR0012489A (es) |
CA (1) | CA2379223A1 (es) |
CO (1) | CO5200765A1 (es) |
CZ (1) | CZ2002192A3 (es) |
DE (1) | DE60007530T2 (es) |
ES (1) | ES2213596T3 (es) |
HK (1) | HK1043797A1 (es) |
HU (1) | HUP0201952A3 (es) |
IL (1) | IL147332A0 (es) |
MX (1) | MXPA02000601A (es) |
NO (1) | NO20020222L (es) |
NZ (1) | NZ516525A (es) |
PE (1) | PE20010330A1 (es) |
PL (1) | PL353007A1 (es) |
RU (1) | RU2002103883A (es) |
SK (1) | SK712002A3 (es) |
TR (1) | TR200200076T2 (es) |
TW (1) | TW548277B (es) |
WO (1) | WO2001005806A1 (es) |
ZA (1) | ZA200200106B (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60004377T2 (de) * | 1999-04-06 | 2004-06-09 | Akzo Nobel N.V. | Oral wirksame 7-alpha-alkyl androgene |
WO2003045398A1 (en) * | 2001-03-30 | 2003-06-05 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Methods of making and pharmaceutical formulations comprising 7alpha, 11beta-dimethy-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof |
US20030069215A1 (en) * | 2001-03-30 | 2003-04-10 | The Government Of The United States Of America, | Methods of making and using 7a,11b-dimethyl-17b-hydroxy-4-estren-3-one 17b-trans-4-n-butylcyclohexane carboxylate and 7a,11b-dimethyl-17b-hydroxyestr-4-en-3-one 17-undecanoate |
AU4966101A (en) * | 2000-03-31 | 2001-10-15 | Us Gov Health & Human Serv | Methods of making and using 7alpha,11beta-dimethyl-17beta-hydroxy-4-estren-3-one17beta-trans-4-m-butylcyclohexane carboxylate and 7alpha,11beta-dimethyl-17beta -hydroxyestr-4-en-3-one 17-undecanoate |
ES2241854T3 (es) * | 2000-07-28 | 2005-11-01 | Akzo Nobel N.V. | Estrogenos de sustitucion metilo o etilo en posicion 16 alfa. |
KR100937179B1 (ko) * | 2002-01-21 | 2010-01-19 | 엔.브이.오가논 | 7α-메틸스테로이드의 제조방법 |
GB0304927D0 (en) * | 2003-03-04 | 2003-04-09 | Resolution Chemicals Ltd | Process for the production of tibolone |
PE20050677A1 (es) | 2003-12-22 | 2005-10-04 | Akzo Nobel Nv | Esteroides con perfil androgenico y progestagenico mixto |
UA89964C2 (ru) | 2004-09-08 | 2010-03-25 | Н.В. Органон | 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ |
WO2010043404A1 (en) * | 2008-10-15 | 2010-04-22 | Synthon B.V. | Processes and intermediates for the production of fulvestrant |
CA2835979C (en) * | 2011-06-01 | 2018-05-01 | Estetra S.A. | Process for the production of estetrol intermediates |
KR101994805B1 (ko) | 2011-06-01 | 2019-07-01 | 에스테트라 에스.피.알.엘. | 에스테트롤 중간체의 제조 방법 |
EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
CN103890001B (zh) * | 2011-10-07 | 2016-05-04 | 埃斯特拉有限责任公司 | 用于制备雌四醇的方法 |
WO2015181116A1 (en) | 2014-05-26 | 2015-12-03 | Crystal Pharma, S.A.U. | Process and intermediades for the preparation of 7-alkylated steroids |
JP6866561B2 (ja) | 2015-06-18 | 2021-04-28 | エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ | エステトロールを含有する口腔内崩壊錠 |
RS60252B1 (sr) | 2015-06-18 | 2020-06-30 | Estetra Sprl | Orodisperzibilna dozna jedinica koja sadrži komponentu estetrola |
CN107750157B (zh) | 2015-06-18 | 2021-07-13 | 埃斯特拉私人有限责任公司 | 含雌四醇的口腔分散片剂 |
PL3106148T3 (pl) | 2015-06-18 | 2018-08-31 | Mithra Pharmaceuticals S A | Jednostka dawkowania ulegająca rozpadowi w jamie ustnej zawierająca składnik estetrolowy |
CA3178291A1 (en) | 2016-08-05 | 2018-04-12 | Estetra Srl | Method for the management of dysmenorrhea and menstrual pain |
CN116693587A (zh) * | 2017-02-23 | 2023-09-05 | 美国西门子医学诊断股份有限公司 | 化学发光雄烯二酮缀合物 |
TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA712312B (en) * | 1970-04-28 | 1972-01-26 | Ochsner Med Found Alton | 4,14-estradiene compounds |
-
2000
- 2000-06-27 TW TW089112646A patent/TW548277B/zh not_active IP Right Cessation
- 2000-07-10 CN CN00810310A patent/CN1360589A/zh active Pending
- 2000-07-10 AT AT00953032T patent/ATE257159T1/de not_active IP Right Cessation
- 2000-07-10 KR KR1020027000566A patent/KR20020092890A/ko not_active Application Discontinuation
- 2000-07-10 MX MXPA02000601A patent/MXPA02000601A/es not_active Application Discontinuation
- 2000-07-10 CZ CZ2002192A patent/CZ2002192A3/cs unknown
- 2000-07-10 AU AU65629/00A patent/AU770412B2/en not_active Ceased
- 2000-07-10 SK SK71-2002A patent/SK712002A3/sk unknown
- 2000-07-10 JP JP2001511464A patent/JP2003505394A/ja not_active Withdrawn
- 2000-07-10 DE DE60007530T patent/DE60007530T2/de not_active Expired - Fee Related
- 2000-07-10 RU RU2002103883/04A patent/RU2002103883A/ru unknown
- 2000-07-10 TR TR2002/00076T patent/TR200200076T2/xx unknown
- 2000-07-10 HU HU0201952A patent/HUP0201952A3/hu unknown
- 2000-07-10 ES ES00953032T patent/ES2213596T3/es not_active Expired - Lifetime
- 2000-07-10 CA CA002379223A patent/CA2379223A1/en not_active Abandoned
- 2000-07-10 EP EP00953032A patent/EP1203011B1/en not_active Expired - Lifetime
- 2000-07-10 PL PL00353007A patent/PL353007A1/xx not_active IP Right Cessation
- 2000-07-10 NZ NZ516525A patent/NZ516525A/xx unknown
- 2000-07-10 IL IL14733200A patent/IL147332A0/xx unknown
- 2000-07-10 BR BR0012489-3A patent/BR0012489A/pt not_active IP Right Cessation
- 2000-07-10 WO PCT/EP2000/006544 patent/WO2001005806A1/en not_active Application Discontinuation
- 2000-07-11 US US09/613,350 patent/US6313108B1/en not_active Expired - Fee Related
- 2000-07-13 CO CO00052876A patent/CO5200765A1/es not_active Application Discontinuation
- 2000-07-14 AR ARP000103625A patent/AR024746A1/es not_active Application Discontinuation
- 2000-07-14 PE PE2000000702A patent/PE20010330A1/es not_active Application Discontinuation
-
2001
- 2001-07-31 US US09/918,626 patent/US6541465B2/en not_active Expired - Fee Related
-
2002
- 2002-01-04 ZA ZA200200106A patent/ZA200200106B/xx unknown
- 2002-01-15 NO NO20020222A patent/NO20020222L/no not_active Application Discontinuation
- 2002-07-24 HK HK02105466.2A patent/HK1043797A1/zh unknown
- 2002-10-24 US US10/280,038 patent/US6780854B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20010330A1 (es) | Androgenos oralmente activos | |
PE20020179A1 (es) | DERIVADOS DE (6S,9R,10S,11S,13S,16R, 17R)-9-CLORO-6-FLUORO-11-HIDROXI-10,13,16-TRIMETIL-3-OXO-6,7,8,9,10,11,12,13,14,15,16,17-DODECAHIDRO-3H-CICLOPENTA[a]FENANTRENO CARBOXILICO | |
PE20070051A1 (es) | Serin-amidas sustituidas con heteroaroilo | |
CO5231161A1 (es) | 4-aminopicolinatos y su uso como herbicidas | |
HRP20090162T1 (en) | Quinolinone-carboxamide compounds as 5-ht4 receptor agonists | |
ES2189502T3 (es) | Metodo para la prevencion de citalopram. | |
PE128799A1 (es) | Quinolinas antimicrobianas y sus composiciones | |
AR018917A1 (es) | Compuestos derivados de adenosina que son agonistas en el receptor adenosina a1, proceso para su preparacion, composiciones farmaceuticas que los contienen. | |
CY1110951T1 (el) | Αζαϊνδολες | |
AR245700A1 (es) | Nuevos derivados de la 2-anilino-pirimidina como agentes antiparasitarios. | |
CO5200848A1 (es) | Derivados de 3(5)-ureido-pirazol, proceso para su prepa- racion y su utilizacion como agentes antitumorales | |
PE55097A1 (es) | Isotiazolonas | |
CO5590895A2 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos | |
AR052682A1 (es) | DERIVADOS DE 5, 6, 7, 8 - TETRAHIDROTIEN[2, 3 - B]QUINOLINA uTILES PARA INHIBIR LA ACTIVIDAD DE QUINESINA DE KSP, COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y SU USO EN EL TRATAMIENTO DE ENFERMEDADES PROLIFERATIVAS. | |
AR009413A1 (es) | Un compuesto, el cual es un derivado de distamicina benzoheterociclico, su utilizacion, un procedimiento para producirlo y una composicionfarmaceutica que lo comprende | |
PE20010962A1 (es) | Derivados de heterociclo-alquilsulfonil-pirazol como agentes anti-inflamatorios/analgesicos | |
AR034206A1 (es) | Un procedimiento para la preparacion de mesilatos de derivados de piperazina y dichos mesilatos | |
PE20011078A1 (es) | PROCEDIMIENTO DE OBTENCION DE LOS DERIVADOS DE DIBENZO [b, f] AZEPINA | |
DK1163258T3 (da) | Derivater af 22R-hydroxycholesta-8, 14-dien til inhiberingen af meiosis | |
JPS5687568A (en) | Imidazoline compound | |
ES2069313T3 (es) | Utilizacion de derivados de tiazoloisoindolinona como medicamentos antiviricos. | |
PE20040693A1 (es) | N-sulfonilaminotiazol como mediadores de la sulfatasa de esteroides | |
MXPA03000845A (es) | Estrogenos substituidos por 16alfa-metilo o etilo. | |
ES443333A1 (es) | Un procedimiento para la produccion de nuevos derivados tri-ciclicos de dibenzazepina. | |
PE20020752A1 (es) | Esteroides con doble enlace delta 14 sustituido en las posiciones 13 y 14 con actividad androgenica y progestagena |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |